​

Acrivon Therapeutics (ACRV) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Acrivon Therapeutics Revenue Highlights

00

Acrivon Therapeutics Revenue by Period

Acrivon Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--

Acrivon Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Acrivon Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$848.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.88M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30--

Acrivon Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Acrivon Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VXRTVaxart$28.70M$39.73M
CBUSCibus$4.26M$933.00K
TCRXTScan Therapeutics$2.82M-
ATYRaTyr Pharma$353.00K$190.00K
RPTXRepare Therapeutics--
RLMDRelmada Therapeutics--
UNCYUnicycive Therapeutics--
BMEABiomea Fusion--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--
IMUXImmunic--

ACRV Revenue FAQ

What is Acrivon Therapeutics’s yearly revenue?

Acrivon Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. ACRV's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Acrivon Therapeutics’s quarterly revenue?

Acrivon Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). ACRV's quarterly revenue for Q4 2024 was $848K, a 100.00% increase from the previous quarter (Q3 2024), and a -54.99% decrease year-over-year (Q4 2023).

What is Acrivon Therapeutics’s revenue growth rate?

Acrivon Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.